{"schema_version":"secwatch.filing_event.v1","accession":"0001636422-22-000027","form_type":"8-K","ticker":"HCAT","cik":"0001636422","company_name":"Health Catalyst, Inc.","filed_at":"2022-06-17T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.578919+00:00","generated_at":"2026-06-25T00:54:01.187583+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Health Catalyst shareholders reject advisory vote on executive compensation at 2022 annual meeting","bullets":["Say-on-pay proposal received 20,019,370 for, 23,100,748 against, 46,068 abstain, 3,010,476 broker non-votes.","Both Class III director nominees elected: Duncan Gallagher (28,400,049 for, 14,766,137 withheld) and Mark B. Templeton (33,605,452 for, 9,560,734 withheld).","Ratification of Ernst & Young as auditor for FY2022 passed: 45,758,062 for, 378,823 against, 39,777 abstain.","Total shares present at meeting: 46,176,662 of 53,937,142 entitled to vote."],"urls":{"canonical":"https://secwatch.observer/filing/0001636422-22-000027","json":"https://secwatch.observer/filing/0001636422-22-000027.json","markdown":"https://secwatch.observer/filing/0001636422-22-000027.md","text":"https://secwatch.observer/filing/0001636422-22-000027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636422/000163642222000027/0001636422-22-000027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636422/000163642222000027/hcat-20220614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T00:54:01.187583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}